Invasive Meningococcal Disease in the Post-COVID-19 Era in South America.

Despite this, there was an increasing trend in the incidence of IMD in the post-pandemic years across all four countries assessed in this study, with the common finding that serogroup B was the predominant serogroup associated with these rebounds.

also in 63,971 other papers

However, in 2022, incidence rates were approximately two times higher (0.23 [497 cases]), and in 2023 approximately three times higher (0.34 [740 cases]) than in 2020 and 2021, showing a clear trend of increasing disease rates.

also in 19,460 other papers